A Food and Drug Administration advisory panel met to discuss regulatory approval for the Alzheimer's drug, Leqembi.
Share:
More In Science
CDC Urges Increased Vaccine Coverage
The Centers for Disease Control and Prevention announced an urgent need to increase vaccination coverage in response to rising respiratory disease levels.
W.H.O. Urges Ban on Flavored Vapes
The World Health Organization has warned that all E-cigarettes should be treated like tobacco and all flavored vapes should be banned.
Trial: Moderna, Merck Vaccine Reduces Cancer Death Rates
Merck and Moderna's cancer vaccine reduces the risk of death by about half, according to mid-stage trial data released Thursday.
1500 Percent Increase in Poison Center Calls
1500 Percent Increase in Poison Center Calls
Be Well: Resistance Band Workout for Lower Body
Resistance Band Workout for Lower Body
Be Well: Breaking the Stigma Around Conversations on Sexual Health
Breaking the Stigma Around Conversations on Sexual Health
Be Well: Understanding Seasonal Affective Disorder
Understanding Seasonal Affective Disorder
Be Well: Five Power Foods for A Longer Life
Five Power Foods for A Longer Life
COP28 Ends With Deal to Transition Away From Fossil Fuels
The COP28 summit in Dubai ended earlier Wednesday with a deal to transition away from using fossil fuels.
